dynaCERT Logo.jpg
dynaCERT Establishes Strategic Alliance with MOSOLF Group of Europe
October 16, 2019 08:58 ET | dynaCERT Inc.
TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) is pleased to announce that it has concluded three (3) agreements...
dynaCERT Logo.jpg
dynaCERT Obtains European Approval of its Hydrogen Technology
August 26, 2019 09:15 ET | dynaCERT Inc.
TORONTO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) is very pleased to announce that its wholly-owned European subsidiary, dynaCERT GmbH,...
dynaCERT Logo.jpg
dynaCERT Strengthens Its Intellectual Property Advancing Global Sustainability
August 22, 2019 05:00 ET | dynaCERT Inc.
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide significant updates related to the...
dynaCERT Logo.jpg
dynaCERT Receives the Notice of Allowance for a Patent for its SMART ECU
May 02, 2019 14:32 ET | dynaCERT Inc.
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a Notice of Allowance...
dynaCERT Logo.jpg
dynaCERT Secures its First Ontario Trucking Fleet Order
April 11, 2019 07:00 ET | dynaCERT Inc.
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a purchase order for...
dynaCERT Logo.jpg
dynaCERT Patent Granted
April 09, 2019 18:04 ET | dynaCERT Inc.
TORONTO, April 09, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that a U.S. patent (U.S. Patent No....
NANOBIOTIX ANNONCE L
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER
April 04, 2019 12:31 ET | NANOBIOTIX
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe...
Nanobiotix Announces
Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval
April 04, 2019 12:31 ET | NANOBIOTIX
NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Announces Appointment of Brian Semkiw to its Advisory Board
March 01, 2019 07:00 ET | dynaCERT Inc.
TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has appointed Mr. Brian Semkiw...
Equillium Logo.png
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
February 07, 2019 08:08 ET | Equillium
LA JOLLA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...